絞り込み

16545

広告

7364件中 101件~120件表示    検索結果をPubMedで見る PubMedで見る

Tyro3 is a podocyte protective factor in glomerular disease.

Homozygous splicing mutation in NUP133 causes Galloway-Mowat syndrome.

Inhibiting the urokinase-type plasminogen activator receptor system recovers STZ-induced diabetic nephropathy.

A Novel CLCN5 Mutation Associated With Focal Segmental Glomerulosclerosis and Podocyte Injury.

Comparative Analysis of Podocyte Foot Process Morphology in Three Species by 3D Super-Resolution Microscopy.

Purinergic 2X7 Receptor is Involved in the Podocyte Damage of Obesity-Related Glomerulopathy via Activating Nucleotide-Binding and Oligomerization Domain-Like Receptor Protein 3 Inflammasome.

New Mutation of Coenzyme Q Monooxygenase 6 Causing Podocyte Injury in a Focal Segmental Glomerulosclerosis Patient.

A Microfluidic Platform for Investigating Transmembrane Pressure-Induced Glomerular Leakage.

Monoclonal light chain crystalline podocytopathy and tubulopathy associated with monoclonal gammopathy of renal significance: a case report and literature review.

APOL1 risk allele RNA contributes to renal toxicity by activating protein kinase R.

The Role of Glucocorticoid Receptors in Podocytes and Nephrotic Syndrome.

Down-regulation of lncRNA XIST ameliorates podocytes apoptosis in membranous nephropathy via miR-217/TLR4 pathway.

Exploring macrophage cell therapy on Diabetic Kidney Disease.

Genetic Testing for Steroid-Resistant-Nephrotic Syndrome in an Outbred Population.

Supplementation of Ameliorates Diabetic Nephropathy and Hepatic Steatosis by Activating Autophagy in Mice.

Preeclampsia: A close look at renal dysfunction.

Generation of two isogenic iPS cell lines (IRFMNi002-A and IRFMNi002-B) from a patient affected by Focal Segmental Glomerulosclerosis carrying a heterozygous c.565G>A mutation in PAX2 gene.

Trichosanthes kirilowii lectin ameliorates streptozocin-induced kidney injury via modulation of the balance between M1/M2 phenotype macrophage.

Growth hormone and chronic kidney disease.

MiR-130a-5p prevents angiotensin II-induced podocyte apoptosis by modulating M-type phospholipase A2 receptor.

  1. 2
  2. 3
  3. 4
  4. 5
  5. 6
  6. 7
  7. 8
  8. 9
  9. 10
  10. 11
Sort by
※並べ替えは表示に時間がかかります